26 related articles for article (PubMed ID: 35227136)
1. Stereotactic ablation: A game changer?
Bale R; Laimer G; Schullian P; Alzaga A
J Med Imaging Radiat Oncol; 2023 Dec; 67(8):886-894. PubMed ID: 37401185
[TBL] [Abstract][Full Text] [Related]
2. High-security automatic path planning of radiofrequency ablation for liver tumors.
Li J; Gao H; Shen N; Wu D; Feng L; Hu P
Comput Methods Programs Biomed; 2023 Dec; 242():107769. PubMed ID: 37714019
[TBL] [Abstract][Full Text] [Related]
3. Navigation and Robotics in Interventional Oncology: Current Status and Future Roadmap.
Charalampopoulos G; Bale R; Filippiadis D; Odisio BC; Wood B; Solbiati L
Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201407
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Thermal Ablation for Small-Size (0-3 cm) versus Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
Dijkstra M; van der Lei S; Puijk RS; Schulz HH; Vos DJW; Timmer FEF; Scheffer HJ; Buffart TE; van den Tol MP; Lissenberg-Witte BI; Swijnenburg RJ; Versteeg KS; Meijerink MR
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686622
[TBL] [Abstract][Full Text] [Related]
5. Unresectable Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial.
van der Lei S; Dijkstra M; Nieuwenhuizen S; Schulz HH; Vos DJW; Versteeg KS; Buffart TE; Swijnenburg RJ; de Vries JJJ; Bruynzeel AME; van den Tol MP; Scheffer HJ; Puijk RS; Haasbeek CJA; Meijerink MR;
Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1076-1085. PubMed ID: 37430016
[TBL] [Abstract][Full Text] [Related]
6. Interventional oncology of liver tumors: how it all started and where are we now.
Solbiati LA; Arai Y
Br J Radiol; 2022 Sep; 95(1138):20220434. PubMed ID: 35776630
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
[TBL] [Abstract][Full Text] [Related]
8. The Role of Radio-Frequency and Stereotactic Ablation in the Treatment of Pancreatic Cancer.
Iancu DM; Buduşan M; Capraş D; Odaini A; Bocşe H; Herdean AI; Boloş T; Breazu CM; Dogaru I; Micu CM; Hajjar NA; Puia CI; Bădulescu CI
Chirurgia (Bucur); 2022 Jun; 117(4):399-406. PubMed ID: 36049096
[TBL] [Abstract][Full Text] [Related]
9. Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Amann A; Effenberger M; Maglione M; Freund MC; Loizides A; Bale R
Eur Radiol; 2021 May; 31(5):3042-3052. PubMed ID: 33125554
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence.
Schullian P; Johnston E; Laimer G; Scharll Y; Putzer D; Eberle G; Kolbitsch C; Amann A; Stättner S; Bale R
HPB (Oxford); 2022 Jul; 24(7):1044-1054. PubMed ID: 34887174
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
[TBL] [Abstract][Full Text] [Related]
14. Technical efficacy and local recurrence after stereotactic radiofrequency ablation of 2653 liver tumors: a 15-year single-center experience with evaluation of prognostic factors.
Schullian P; Laimer G; Johnston E; Putzer D; Eberle G; Scharll Y; Widmann G; Kolbitsch C; Bale R
Int J Hyperthermia; 2022; 39(1):421-430. PubMed ID: 35227136
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
